Skip to main content

US ClosedU.S. Closed

LRMR: Larimar Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm.

52W Range

35thpctl

Volume

0.34×avg

Market Cap

416.57MUSD

P/E Ratio

-2.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Larimar Therapeutics, Inc.

LRMRNASDAQ Global Market·USD·Closed

Larimar Therapeutics, Inc.

LRMRNASDAQ·USD·Closed

$4.01

−0.99%

$4.01

−$0.04 (0.99%)

52W Range

35thpctl

Volume

0.34×avg

Mkt Cap

416.57MUSD

P/E

-2.0TTM

Div Yield

–ann